Posted On: 11/13/2015 7:15:39 AM
Post# of 72446
Thanks Drano. Guess I missed that post.
That potential alone is amazing imo. I think we're getting close and closer to seeing kevetrin back in the headlines. Waiting on DF to give up some solid data is painful. Cohorts are finished right? Come on come on come on!!!!!
Quote:
If studies confirm Brilacidin is broad spectrum, effective. and well tolerated it will be widely prescribed. Several studies show a significant number of Doctor and ER visits are due to eye infections. It will be prescribed by primary care docs, pediatricians, ER Docs, nurse practioners ,in addition to ophthalmologists and optometrists. The last time I checked the market for topical ophthalmic antibiotics was several hundred million dollars in the US.
That potential alone is amazing imo. I think we're getting close and closer to seeing kevetrin back in the headlines. Waiting on DF to give up some solid data is painful. Cohorts are finished right? Come on come on come on!!!!!
(0)
(0)
